Phase 3 Fuchs Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Descemet Endothelial Thickness Comparison Trial II
Fuchs' Endothelial DystrophyFuchs DystrophyFuchs
Stanford University60 enrolled8 locationsNCT05275972
Recruiting
Phase 3
AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Corneal EdemaCorneal Endothelial DysfunctionFuchs Endothelial Corneal Dysfunction+1 more
Aurion Biotech120 enrolled12 locationsNCT07368959
Recruiting
Phase 3
The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
CataractFuchs' Endothelial Dystrophy
Singapore Eye Research Institute120 enrolled1 locationNCT06048380